Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2011-05-03
2011-05-03
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
C548S101000
Reexamination Certificate
active
07935728
ABSTRACT:
The invention relates to cyclopalladated compounds containing bis-diphenylphosphine-ferrocene ligands and their analogues which are active inhibitors of proteins and enzymes, for example, those of the serine peptidase, cysteine-protease, metalo-protease and endopeptidase families, involved in the development and metastases of malignant tumors, e.g. of the thyroid. An exemplary compound is shown in the figure. The compounds are able to modulate the immunological system due to their action on the enzymes and their interaction with DNA molecules.
REFERENCES:
patent: 5880149 (1999-03-01), Grinstaff et al.
A.C.F. Caires, Anti-cancer Agents in Medicinal Chemistry, 2007,7:1-8.
Ma et al., 2000, CAS: 132:321958.
* Ares, Raquel , et al., “Functionalized cyclopalladated compounds with bidentateGroup 15 donor atom ligands: the crystaland molecular structures of [{Pd[5-(COH)C6H3C(H)=NCy-C2,N](C1)}2(μ-Ph2PRPPh2)] (R = CH2CH2, Fe (C5H4)2], [Pd {5-(COH)C6H3C( H)=NCy-C2,N)-(Ph2PCH2PPh2-P,P)][PF6] and [Pd{5-(COH)C6H3C(H)=N(Cy)-C2,N} (Ph2PCH2CH2AsPh-P,As)][PF6]”, Journal of Organometallic Chemistry, 665(1-2):76-86 (2003).
* Fernandez, Alberto, et al., “The first crystal and molecular structure of a syn-acetato-bridged dinuclear cyclometallated complex [Pd{2,3,4-(Me0)3C6HC(H)=NCH2CH20H-(μ-OAc)]2”, Eur. J. Inorg. Chem., 9:2389-2401 (Sep. 2002).
* Fernandez, Alberto, et al., “Cyclopalladated compounds derived from a [C,N,S] terdentate ligand: synthesis, characterization and reactivity. Crystal and molecular structures of [Pd{2-CIC6H3C(H)=NCH2CH2SMe}(C1)] and {Pd [2-C1C6H3C(H)=NCH2CH2SMe]}2 {μ-Ph2P(CH2)4PPh2}]-CF3SO3]2” New J. Chem., 26(1):105-112 (Jan. 2002).
* Vila, Jose M., et al., “Novel cyclopalladated ferrocenyl Schiff base compounds with bridging and chelating diphosphines. Crystal and molecular structure of [{Pd [(η5-C5H5)Fe(η5- C5H3)C(H):N-2,4,6-Me3C6H2]}-Ph2P(CH2)nPPh2-P,P}][PF6] (n = 1, 2)”, Journal of Organometallic Chemistry, ( 637-639): 577-585 (Dec. 2001).
* Castro-Juiz, Samuel, et al., “Directed regioselectivity in cyclometallated palladium(II) compounds of N-benzyl1denebenzylamines. Crystal and molecular structure of [Pd{3,4-(OCH2O)C6H2C(H)=NCH2-[3,4-(OCH2O)C6H3]-C2,N)(μ-O2CMe)]2”, Polyhedron, 20:2925-2933 (2001).
* Ananias, Sandra R., et al., “Cleavage of the dimeric cyclopalladated IPd(N,C-dmba)(μ.-X) 12, (dmba = N,N-dimethylbenzylamine; X = SCN and NCO) by diphosphines. Palladium(II) compounds with distinct structures in the solid-state and in solution”,Transition Metal Chemistry, 26(4-5): 570-573 (Dordrecht, Netherlands: 2001).
* Lousame, Mariela, et al., “Synthesis and single-crystal X-ray diffraction studies of new cyclometallated phenylimidazole palladium (II) compounds”, Eur. J. Inorga. Chem., 9:2055-2062 (Sep. 2000).
* Ma, Jian-Fang, et al., “Reaction of di-μ.-dichloro-bis(N,N-dimethylbenzylamine- C2,N)dipalladium(II) with diphosphines. Six-membered ring complexes bearing spiro rings”, Inorganica Chimica Acta, 299(2): 164-171 (Mar. 2000).
* Boehm, Andreas, et al., “Metal complexes of biologically important ligands. Part 104. Ortho-palladated complexes of N,N-dimethyl(phenyl)glycine methyl ester. Synthesis of.alpha.-amino acid derivatives by insertion of isocyanides, CO, alkenes, and alkynes into the Pd-C bond”, Zeitschrift Fuer Naturforschung, B Chemical Sciences, 53(4):448-458 (1998).
* Zhao, Gang, et al., “Optically active cyclopalladated derivatives of arylimines. Crystal structures of (+)-[{Pd[p-MeOC6H3CH=NCH2-(1S,2R,5S)-CHCH2CH2CHC(Me)2CHCH2](μ-X}2 (X = C1 or Br), (+)-[Pd{p-MeOC6H3CH=NCH2-(1S,2R,5S)-CHCH2-CH2CHC(Me)2CHCH2}CI(PPh3)] and (+)-[{Pd[p-MeOC6H3CH=NCH2-(1S,2R,5S)- CHCH2CH2CHC(Me)2CHCH2]CI}2-{Fe(η5H4PPh2)2}], ”J. Chem. Soc., Dalton Transactions: Inorganic Chemistry, 7:1241-1247 (1998).
* Zhao, Gang, et al., “DiastereoselectiveCyclopalladation of New Chiral Ferrocenylimines (-)[(η5-C5H5)Fe{η.5-C5H4C(R)=NCH2-(1S,2R,5S)- CHCH2CH2CHC(CH3)2CHCH2}]. Crystal Structures of (Sp)[Pd{(η5-C5H3C(R)=NCH2-(1S,2R,5S)-CHCH2CH2CHC(CH3)2 CHCH2)Fe(η5-C5H5)}(PPh3)C1] (R = H or Me)”, Organometallics 16(18): 4023-4026 (1997).
* Quiroga, A. G., et al., “Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-iospropylbenzaldehyde thiosemicarbazone with cytostatic activity in cis-DDP resistant tumor line cells. Interaction of these complexes with DNA”, J. Med. Chem., 41(9): 1399-1408 (Apr. 1998).
* Navarro-Ranninger, Carmen, et al., “Cyclometalated complexes of platinum and palladium with N-(4-chlorophenyl)-alpha-benzoylbenzylideneamine. In vitro cytostatic activity, DNA modification and interstrand cross-link studies”, Inorg. Chem. 35(18): 5181-5187 (Aug. 1996).
* Navarro-Ranninger, C., et al., “Analysis of two cycloplatinated compounds derived from N-(4-methoxyphenyl)-alpha-benzoylbenzylidenamide: Comparison of the activity of these compounds with other isostructural cyclopalladated compounds”, J. Med. Chem. 36(24): 3795-3801 (Nov. 1993).
* Ares, Raquel, et al., “Cyclopalladated compounds with bridging and chelating diphosphine ligands Effect of ring size. Crystal and molecular structure of [{Pd[4-(COH)C6H3C(H)=N(Cy)-C2,N](C1) }2(μ-Ph2PCH2PPh2)]” Polyhedron, 21(22):2309-2315 (2002).
Barbosa et al., Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells—European Journal of Pharmacology 542 (2006) 37-47.
Bincoletto et al., Chiral cyclopalladated complexes derived from N, N-dimethyl-1-phenethylamine with bridging bis (diphenylphosphine) ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents—Bioorganic & Medicinal Chemistry 13 (2005) 3047-3055.
Caires, A.C.F., Recent Advances Involving Palladium (II) Complexes for the Cancer Therapy—Anti-Cancer Agents in Medicinal Chemistry, 2007, vol. 7, No. 5, pp. 1-8—2007 Bentham Science Publishers Ltd.
Rodrigues et al., Cyclopalladated Compounds As Chemotherapeutic Agents: Antitumor Activity Against A Murine Melanoma Cell Line—Int. J. Cancer: 107, 498-504 (2003).
Ananias et al., Cleavage of the dimeric cyclopalladated [Pd(N, C-dmba)(μ-X)]2, (dmba = N, N-dimethylbenzylamine; X = SCN and NCO) by diphosphines. Palladium(II) compounds with distinct structures in the solid-state and in solution—Transition Metal Chemistry 26: 570-573, 2001.
Caires Antonio Carlos Fávero
Tersariol Ivarne Luis dos Santos
Trindade Claudia Bincoletto
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
Shiao Rei-tsang
Volpe and Koenig P.C.
LandOfFree
Cyclic palladium compounds having coordinated thereto bis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic palladium compounds having coordinated thereto bis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic palladium compounds having coordinated thereto bis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2632869